APC and colorectal cancer: While studies have identified APC as a driver of multidrug resistance through the Wnt/β-catenin signaling in colorectal cancer [46–49], we have not thoroughly discussed this body of work since we previously reported the effects of Apc mutation in the MMTV-PyMT mouse model to be independent of Wnt/β-catenin signaling [23].